G1 therapy: Results indicate that the use of Trilaciclib and Trop2 ADC may be associated with improving median OS compared to historical data using ADC alone.
G1 疗法：结果表明与单独使用ADC的历史数据相比使用Trilaciclib和Trop2 ADC可能与改善中位Os有关
G1 therapy: Results suggest that using Trilaciclib and Trop2 ADCs may be associated with improving median OS compared to historical data using ADC alone
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.